These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 2663486)
1. Endocrine therapy of breast and prostate cancer. Manni A Endocrinol Metab Clin North Am; 1989 Jun; 18(2):569-92. PubMed ID: 2663486 [TBL] [Abstract][Full Text] [Related]
2. Management of breast cancer. Cohen IA; Keller JH; Abate MA Clin Pharm; 1982; 1(6):515-29. PubMed ID: 6192963 [TBL] [Abstract][Full Text] [Related]
4. Cancer of the breast. Endocrine and hormonal therapy. Kardinal CG; Donegan WL Major Probl Clin Surg; 1979; 5():361-404. PubMed ID: 379452 [TBL] [Abstract][Full Text] [Related]
5. Regarding: Valero V, Buzdar AU, Hortobagyi GN. "Locally Advanced Breast Cancer," The Oncologist 1996;1:8-17. Oliver RT Oncologist; 1996; 1(4):278-279. PubMed ID: 10388003 [TBL] [Abstract][Full Text] [Related]
6. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches. Hoffmann J; Sommer A J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262 [TBL] [Abstract][Full Text] [Related]
7. Content of epidermal growth factor receptor in metastatic breast cancer: its role in endocrine sensitivity prediction. Nesković-Konstantinović ZB; Nikolić-Vukosavljević DB; Branković-Magić MV; Mitrovic LB; Spuzić I Neoplasma; 2000; 47(2):107-13. PubMed ID: 10985476 [TBL] [Abstract][Full Text] [Related]
8. Aromatase inhibitors for treatment of breast cancer: current concepts and new perspectives. Santen RJ Breast Cancer Res Treat; 1986; 7 Suppl():S23-35. PubMed ID: 3527304 [TBL] [Abstract][Full Text] [Related]
9. Endocrine management of breast cancer. Schneider PG; Jackisch C; Brandt B Int J Fertil Menopausal Stud; 1994; 39 Suppl 2():115-27. PubMed ID: 7874188 [TBL] [Abstract][Full Text] [Related]
10. [Endocrine therapy of breast cancer. Status and perspectives]. Jänicke F Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):677-86. PubMed ID: 3069556 [TBL] [Abstract][Full Text] [Related]
11. Steroid receptors in breast cancer. Desombre ER Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047 [TBL] [Abstract][Full Text] [Related]
12. Aromatase inhibitors: rationale for use following antiestrogen therapy. Yue W; Santen RJ Semin Oncol; 1996 Aug; 23(4 Suppl 9):21-7. PubMed ID: 8824461 [TBL] [Abstract][Full Text] [Related]
13. Endocrine manipulation in advanced breast cancer: recent advances with SERM therapies. Johnston SR Clin Cancer Res; 2001 Dec; 7(12 Suppl):4376s-4387s; discussion 4411s-4412s. PubMed ID: 11916228 [TBL] [Abstract][Full Text] [Related]
14. Optimal treatment strategies in postmenopausal women with hormone-receptor-positive and HER2-negative metastatic breast cancer. Gligorov J; Lotz JP Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():53-66. PubMed ID: 19101794 [TBL] [Abstract][Full Text] [Related]
15. The use of endocrine therapy. Pritchard KI; Sutherland DJ Hematol Oncol Clin North Am; 1989 Dec; 3(4):765-805. PubMed ID: 2481670 [TBL] [Abstract][Full Text] [Related]
16. Adjuvant therapy for breast cancer. NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506 [TBL] [Abstract][Full Text] [Related]
17. Prediction of recurrence for advanced breast cancer. Traditional and contemporary pathologic and molecular markers. Masood S Surg Oncol Clin N Am; 1995 Oct; 4(4):601-32. PubMed ID: 8535901 [TBL] [Abstract][Full Text] [Related]
18. Optimizing the treatment of metastatic breast cancer. Gralow JR Breast Cancer Res Treat; 2005; 89 Suppl 1():S9-S15. PubMed ID: 15770536 [TBL] [Abstract][Full Text] [Related]
19. [Hormone therapy--recent advances]. Matsumoto K; Noguchi S Gan To Kagaku Ryoho; 1987 Oct; 14(10):2816-23. PubMed ID: 2959202 [TBL] [Abstract][Full Text] [Related]
20. Aromatase inhibitors and breast cancer. Miller WR Minerva Endocrinol; 2006 Mar; 31(1):27-46. PubMed ID: 16498362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]